Literature DB >> 16647533

Helicobacter pylori: a possible association with otitis media with effusion.

Taner Yilmaz1, Mehmet Ceylan, Yakut Akyön, Olcay Ozçakýr, Bülent Gürsel.   

Abstract

OBJECTIVE: Evaluate possible role of Helicobacter Pylori in pathogenesis of otitis media with effusion (OME). STUDY DESIGN AND
SETTING: Randomized controlled trial, tertiary referral center. STUDY GROUP: Middle ear fluid was aspirated, a biopsy was taken from the promontorium of 22 children with OME. CONTROL GROUP: A small biopsy was taken from the promontorium of 20 children with normal otologic findings. For both groups, 5 mm deep tissue specimens were obtained from tonsil and adenoid.
RESULTS: H pylori presence in the middle ear, the tonsillar and adenoid tissues by culture and PCR was significantly more frequent in the study group compared to the control group (P<0.05).
CONCLUSIONS: This study is the first to grow H pylori in middle ear in OME. Significantly increased colonization by H pylori of the middle ear, and tonsillar and adenoid tissue in patients with OME indicates that the bacteria might be involved in the pathogenesis of OME. EBM RATING: A-1b.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647533     DOI: 10.1016/j.otohns.2006.02.002

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  20 in total

Review 1.  Extragastric diseases associated with Helicobacter pylori infection.

Authors:  Karen J Goodman; Stephanie L Joyce; Kathleen P Ismond
Journal:  Curr Gastroenterol Rep       Date:  2006-12

2.  The Role of Helicobacter pylori in Upper Respiratory System Infections: Is it More Than Colonization?

Authors:  Mucahit Yemisen; Bilgul Mete; Asiye Kanbay; Ilker Inanc Balkan; Resat Ozaras
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 3.  An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction?

Authors:  Shin Kariya; Mitsuhiro Okano; Kazunori Nishizaki
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

4.  Helicobacter pylori isolated from patients with tonsillar cancer or tonsillitis chronica could be of different genotype compared to isolates from gastrointestinal tract.

Authors:  E Pavlík; P Lukes; B Potuzníková; J Astl; P Hrdá; A Soucek; P Matucha; J Dosedĕl; I Sterzl
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.099

5.  Does Helicobacter pylori exist in vocal fold pathologies and in the interarytenoid region?

Authors:  Ahmet Islam; Haldun Oguz; Mihriban Yucel; Gökhan Koca; Mehmet A Gonultas; Necmi Arslan; Münir Demirci
Journal:  Dysphagia       Date:  2013-01-13       Impact factor: 3.438

Review 6.  Laryngopharyngeal reflux and Helicobacter pylori.

Authors:  Taner Yılmaz; Münir Demir Bajin; Rıza Önder Günaydın; Serdar Ozer; Tevfik Sözen
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Presence of different genotypes of Helicobacter pylori in patients with chronic tonsillitis and sleep apnoea syndrome.

Authors:  Eva Nártová; Jaroslav Kraus; Emil Pavlík; Petr Lukeš; Rami Katra; Jan Plzák; Libuše Kolářová; Ivan Sterzl; Jan Betka; Jaromír Astl
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-18       Impact factor: 2.503

8.  Incidence of Helicobacter pylori infection and their clarithromycin-resistant strains in otitis media with effusion regarding phenotypic and genotypic studies.

Authors:  Nahla A Melake; Ghada H Shaker; Magdy A Salama
Journal:  Saudi Pharm J       Date:  2012-03-03       Impact factor: 4.330

9.  Relationship between Helicobacter pylori Adenotonsillar Colonization and Frequency of Adenotonsillitis in Children.

Authors:  Oğuz Güçlü; Alper Akçalı; Erkan Melih Sahin; Kazım Tekin; Ozan Barutçu; Müşerref Tatman Otkun; Fevzi Sefa Dereköy
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

10.  Expression of inflammatory mediators in the otitis media induced by Helicobacter pylori antigen in mice.

Authors:  S Kariya; M Okano; K Fukushima; S Nomiya; Y Kataoka; R Nomiya; H Akagi; K Nishizaki
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.